Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Expert Review of Anticancer Therapy
|
October 5, 2024
Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions
Aram Bidikian, Jan P Bewersdorf, Rory M Shallis, et al.
Blood Advances
|
August 2, 2022
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
Rong Wang, Rory M Shallis, Jessica M Stempel, et al.
Blood Advances
|
March 20, 2023
Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence
Rory M Shallis, Rong Wang, Amer M Zeidan, et al.
Blood Neoplasia
|
November 11, 2025
Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib
Rong Wang, Jessica M Stempel, Rory M Shallis, et al.
Blood Advances
|
September 18, 2025
Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis
Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles, et al.
JCO Global Oncology
|
December 2, 2024
Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database
Abdulrahman Alhajahjeh, Lara K Rotter, Jessica M Stempel, et al.
Leukemia & Lymphoma
|
November 19, 2024
Cost-effectiveness of Enasidenib versus conventional care for older patients with <i>IDH2-</i>mutant refractory/relapsed AML
Abdulrahman Alhajahjeh, Kishan K Patel, Rory M Shallis, et al.
Cancer Medicine
|
September 13, 2023
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia
Nikolai A Podoltsev, Rong Wang, Rory M Shallis, et al.
Leukemia & Lymphoma
|
October 23, 2024
Analyzing determinants of premature trial discontinuation in leukemia clinical trials
Lara K Rotter, Abdulrahman Alhajahjeh, Jessica M Stempel, et al.
Leukemia & Lymphoma
|
September 3, 2024
Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights
Tinatin Muradashvili, Yuxin Liu, Jennifer VanOudenhove, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Expert Review of Anticancer Therapy
|
October 5, 2024
Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions
Aram Bidikian, Jan P Bewersdorf, Rory M Shallis, et al.
Blood Advances
|
August 2, 2022
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
Rong Wang, Rory M Shallis, Jessica M Stempel, et al.
Blood Advances
|
March 20, 2023
Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence
Rory M Shallis, Rong Wang, Amer M Zeidan, et al.
Blood Neoplasia
|
November 11, 2025
Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib
Rong Wang, Jessica M Stempel, Rory M Shallis, et al.
Blood Advances
|
September 18, 2025
Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis
Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles, et al.
JCO Global Oncology
|
December 2, 2024
Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database
Abdulrahman Alhajahjeh, Lara K Rotter, Jessica M Stempel, et al.
Leukemia & Lymphoma
|
November 19, 2024
Cost-effectiveness of Enasidenib versus conventional care for older patients with <i>IDH2-</i>mutant refractory/relapsed AML
Abdulrahman Alhajahjeh, Kishan K Patel, Rory M Shallis, et al.
Cancer Medicine
|
September 13, 2023
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia
Nikolai A Podoltsev, Rong Wang, Rory M Shallis, et al.
Leukemia & Lymphoma
|
October 23, 2024
Analyzing determinants of premature trial discontinuation in leukemia clinical trials
Lara K Rotter, Abdulrahman Alhajahjeh, Jessica M Stempel, et al.
Leukemia & Lymphoma
|
September 3, 2024
Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights
Tinatin Muradashvili, Yuxin Liu, Jennifer VanOudenhove, et al.
Page
of 4